Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio Clementi

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Circulation Research|June 25, 2005
In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarctionRuggiero Mango, Silvia Biocca, Francesca del Vecchio, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 13, 2008
A randomized trial comparing eptifibatide vs. placebo in patients with diffuse coronary artery disease undergoing drug-eluting stent implantation: design of the INtegrilin plus STenting to Avoid myocardial Necrosis TrialGiuseppe G L Biondi-Zoccai, Marco Valgimigli, Imad Sheiban, et al.
International Journal of Cardiology|February 25, 2012
Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thrombosesFabrizio D'Ascenzo, Mario Bollati, Fabrizio Clementi, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Circulation Research|June 25, 2005
In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarctionRuggiero Mango, Silvia Biocca, Francesca del Vecchio, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 13, 2008
A randomized trial comparing eptifibatide vs. placebo in patients with diffuse coronary artery disease undergoing drug-eluting stent implantation: design of the INtegrilin plus STenting to Avoid myocardial Necrosis TrialGiuseppe G L Biondi-Zoccai, Marco Valgimigli, Imad Sheiban, et al.
International Journal of Cardiology|February 25, 2012
Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thrombosesFabrizio D'Ascenzo, Mario Bollati, Fabrizio Clementi, et al.
Pageof 2